Singapore, March 26, 2008:  PerkinElmer, a global technology leader in Health Sciences and Photonics from USA has appointed Dr John E. Sherwin as director of laboratory operations for its genetic screening business. He will be reporting to Ms Ann-Christine Sundell, president of genetic screening, PerkinElmer.

 

In this role, a prepared company release said, he will be responsible for overseeing and directing the growth of PerkinElmer’s genetic screening laboratory services offerings, including PerkinElmer Genetics, a neonatal screening reference laboratory, and NTD Laboratories, a reference laboratory specializing in prenatal risk assessment.

 

Dr Sherwin has over 3 decades of pediatric and perinatal laboratory medicine experience, including nearly 20 years directing laboratories at hospitals in Chicago and Fresno, California. He joins PerkinElmer from the State of California, where he most recently served as acting chief of the Genetic Disease Branch, responsible for the operation of the State’s entire prenatal and newborn screening program – the largest such program in the world.

 

Before this, he was chief of the California Genetic Disease Laboratory for eight years. He has also held positions as senior technical director, general manager and chief operating officer of multimillion-dollar reference laboratories and has been a consultant to a variety of businesses and physician practices.

 

Dr Sherwin is a past president of both the American Association for Clinical Chemistry and the National Academy of Clinical Biochemistry. He is active in the Association of Public Health Laboratories, and is a member of the governing council of the International Society for Newborn Screening. He holds a PhD in biological science from the University of California, Santa Barbara and a bachelor’s degree in biology from the University of Arizona, Tucson.